Urgent

Severe influenza pneumonia

Infection · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Primary viral pneumonia or influenza with secondary bacterial infection causing severe hypoxaemic respiratory failure, particularly in the elderly, pregnant, immunocompromised or those with chronic disease.

Red flags

  • Rapidly progressive hypoxaemia despite oxygen
  • Haemodynamic instability / secondary sepsis
  • Haemoptysis or cavitation (necrotising staphylococcal infection)
  • Pregnancy or immunosuppression

Assessment

Differential diagnosis

  • COVID-19 or other viral pneumonia
  • Bacterial community-acquired pneumonia
  • Secondary bacterial pneumonia (S. aureus, S. pneumoniae)
  • ARDS from other cause
  • Cardiogenic pulmonary oedema

Investigations

  • Nasopharyngeal swab for influenza PCR
  • CXR (bilateral infiltrates)
  • ABG / SpO2
  • FBC, U&E, CRP, LFTs
  • Blood cultures and pneumococcal/atypical screen if secondary infection suspected

Management

  • Isolate with droplet precautions
  • Give controlled oxygen; escalate to HFNO/NIV/ventilation as needed
  • Start antiviral therapy early (best within 48 h but give if severe regardless of onset)
  • Cover secondary bacterial infection empirically if clinical/radiological suspicion (including MRSA in severe cases)
  • Support organ function and consider ICU for refractory hypoxaemia
  • Consider ECMO referral for refractory ARDS

Drugs & doses

Oseltamivir (or IV/inhaled zanamivir if enteral route unavailable)
Empirical antibiotics for secondary bacterial pneumonia if suspected
Oxygen / respiratory support
Antipyretics / supportive care

Disposition

Admit; HDU/ICU for respiratory support; ECMO centre referral if refractory.

Complications & pitfalls

  • ARDS
  • Secondary bacterial pneumonia
  • Myocarditis / rhabdomyolysis
  • Multi-organ failure

Exam pearls

  • Do not delay antivirals for the swab result in severe or high-risk disease
  • Necrotising pneumonia with influenza suggests Panton-Valentine leukocidin S. aureus - consider anti-toxin cover
  • Neuraminidase inhibitors still benefit late presentation when critically ill

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.